ACLIDINIUM BROMIDE

ACLIDINIUM BROMIDE was reported 6392 times

ACLIDINIUM BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOTAL LUNG CAPACITY INCREASED 140 0.5147
1 BLOOD PRESSURE AMBULATORY ABNORMAL 7 0.3889
2 HYPER IGE SYNDROME 44 0.3860
3 CONGENITAL HIATUS HERNIA 82 0.3596
4 OCCUPATIONAL ASTHMA 20 0.3448
5 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 146 0.2792
6 DYSPONESIS 4 0.2667
7 ALVEOLAR OSTEITIS 68 0.1608
8 FUNGAL DISEASE CARRIER 15 0.1485
9 URINARY TRACT DISCOMFORT 68 0.1475
10 AIRWAY REMODELLING 16 0.1290
11 FORCED EXPIRATORY VOLUME INCREASED 7 0.1186
12 NEUROSENSORY HYPOACUSIS 14 0.1157
13 MYCOBACTERIUM TEST POSITIVE 23 0.1117
14 MALIGNANT MELANOMA STAGE 0 22 0.1053
15 LUNG DIFFUSION DISORDER 15 0.0955
16 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 71 0.0766
17 INTENTIONAL DEVICE MISUSE 336 0.0761
18 MUSCLE TENSION DYSPHONIA 6 0.0750
19 COLOPATHY 4 0.0741
20 ANIMAL SCRATCH 66 0.0678
21 GALACTOSTASIS 3 0.0612
22 LUNG DIFFUSION TEST DECREASED 23 0.0576
23 EOSINOPHILIC BRONCHITIS 11 0.0550
24 VITAL CAPACITY DECREASED 24 0.0536
25 BRONCHIECTASIS 354 0.0525
26 RESTRICTIVE PULMONARY DISEASE 60 0.0512
27 MALIGNANT MELANOMA IN SITU 60 0.0484
28 NASAL POLYPS 232 0.0471
29 PRESBYACUSIS 14 0.0455
30 OESOPHAGEAL DILATATION 20 0.0452
31 SINUS PAIN 102 0.0437
32 INGUINAL HERNIA REPAIR 14 0.0417
33 INTERCHANGE OF VACCINE PRODUCTS 3 0.0417
34 OBSTRUCTIVE AIRWAYS DISORDER 450 0.0404
35 NSAID EXACERBATED RESPIRATORY DISEASE 15 0.0397
36 PANCREATIC CALCIFICATION 5 0.0385
37 FEMALE STERILISATION 19 0.0370
38 TUNNEL VISION 68 0.0363
39 ALPHA-1 ANTITRYPSIN DEFICIENCY 3 0.0341
40 RHINITIS ALLERGIC 143 0.0321
41 BREATH SOUNDS ABNORMAL 157 0.0318
42 CARCINOMA IN SITU 5 0.0299
43 SARCOIDOSIS 142 0.0299
44 POLYCYSTIC OVARIES 46 0.0296
45 BREAST CONSERVING SURGERY 15 0.0293
46 PERICARDIAL FIBROSIS 4 0.0288
47 LAPAROSCOPIC SURGERY 6 0.0276
48 JAUNDICE CHOLESTATIC 97 0.0274
49 POLYMYALGIA RHEUMATICA 84 0.0264
50 HYPOMANIA 94 0.0255
51 EAR CONGESTION 68 0.0251
52 BLOOD IMMUNOGLOBULIN E DECREASED 4 0.0248
53 VOCAL CORD POLYP 7 0.0248
54 CAROTID ARTERIOSCLEROSIS 25 0.0242
55 BLADDER PAIN 74 0.0233
56 RESPIRATORY TRACT OEDEMA 17 0.0229
57 LIPOHYPERTROPHY 14 0.0225
58 PNEUMOTHORAX SPONTANEOUS 15 0.0221
59 ATOPY 6 0.0216
60 BRONCHIAL OBSTRUCTION 30 0.0214
61 BRONCHIAL WALL THICKENING 15 0.0209
62 FULL BLOOD COUNT ABNORMAL 220 0.0208
63 POSITIVE AIRWAY PRESSURE THERAPY 6 0.0205
64 STRESS URINARY INCONTINENCE 22 0.0204
65 WOUND COMPLICATION 68 0.0198
66 DEVICE FAILURE 296 0.0194
67 BRONCHITIS CHRONIC 46 0.0188
68 PARANASAL SINUS DISCOMFORT 71 0.0187
69 DEVICE MALFUNCTION 1282 0.0182
70 PULMONARY EOSINOPHILIA 8 0.0175
71 WOUND SECRETION 68 0.0173
72 CALCULUS URINARY 26 0.0169
73 OROPHARYNGEAL CANDIDIASIS 15 0.0166
74 CHRONIC SINUSITIS 62 0.0165
75 CARDIAC MURMUR 142 0.0164
76 BENIGN PROSTATIC HYPERPLASIA 84 0.0163
77 PRODUCT ADMINISTERED BY WRONG PERSON 6 0.0157
78 MITRAL VALVE REPAIR 5 0.0155
79 SPUTUM ABNORMAL 10 0.0151
80 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 784 0.0150
81 NEPHRECTOMY 22 0.0148
82 SPUTUM DISCOLOURED 140 0.0147
83 BODY HEIGHT DECREASED 150 0.0140
84 REVERSIBLE AIRWAYS OBSTRUCTION 7 0.0138
85 TOTAL LUNG CAPACITY DECREASED 22 0.0138
86 RALES 80 0.0138
87 CREPITATIONS 41 0.0138
88 SPUTUM PURULENT 9 0.0137
89 BREAST NEOPLASM 14 0.0136
90 VOCAL CORD INFLAMMATION 4 0.0136
91 MYOPATHY 112 0.0130
92 PAROTITIS 15 0.0129
93 FORCED EXPIRATORY VOLUME DECREASED 36 0.0127
94 ORTHOSTATIC INTOLERANCE 9 0.0125
95 MACROCYTOSIS 14 0.0121
96 PERSONAL RELATIONSHIP ISSUE 8 0.0120
97 KYPHOSIS 21 0.0119
98 PULMONARY FUNCTION TEST DECREASED 51 0.0116
99 GRANULOMATOSIS WITH POLYANGIITIS 14 0.0116
100 LORDOSIS 4 0.0114
101 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 7 0.0113
102 WHEEZING 666 0.0112
103 STENOTROPHOMONAS INFECTION 15 0.0111
104 HYPERCAPNIA 33 0.0109
105 INSPIRATORY CAPACITY DECREASED 3 0.0108
106 EMPHYSEMA 109 0.0108
107 ANGIOPLASTY 16 0.0107
108 LUNG NEOPLASM 44 0.0103
109 HYPERCHOLESTEROLAEMIA 95 0.0098
110 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 165 0.0097
111 BLOOD IRON DECREASED 113 0.0095
112 SINUSITIS BACTERIAL 10 0.0095
113 PERICARDITIS CONSTRICTIVE 4 0.0095
114 DYSLIPIDAEMIA 48 0.0094
115 NOCTURNAL DYSPNOEA 12 0.0094
116 ALLERGY TO ANIMAL 10 0.0094
117 LUNG HYPERINFLATION 8 0.0093
118 PAINFUL RESPIRATION 22 0.0091
119 BREAST HAEMORRHAGE 3 0.0091
120 INTENTIONAL PRODUCT MISUSE 741 0.0085
121 PULMONARY FUNCTION TEST ABNORMAL 13 0.0083
122 SCHIZOPHRENIA 97 0.0080
123 NASAL DISCHARGE DISCOLOURATION 11 0.0080
124 LUNG OPACITY 21 0.0080
125 HYPERSENSITIVITY PNEUMONITIS 9 0.0079
126 OBSTRUCTIVE PANCREATITIS 6 0.0078
127 PRODUCTIVE COUGH 363 0.0076
128 LUNG CONSOLIDATION 21 0.0075
129 JOINT INJURY 157 0.0073
130 ASTHMA 819 0.0072
131 RHONCHI 10 0.0072
132 MICTURITION URGENCY 82 0.0072
133 BRONCHIOLITIS 25 0.0071
134 BLOOD IMMUNOGLOBULIN E INCREASED 17 0.0070
135 SINUS DISORDER 139 0.0070
136 AORTIC ARTERIOSCLEROSIS 18 0.0070
137 GRANULOMA 24 0.0069
138 INCORRECT DOSE ADMINISTERED BY PRODUCT 11 0.0069
139 GLOSSITIS 24 0.0068
140 OBSTRUCTION 27 0.0068
141 SKIN LACERATION 73 0.0067
142 ADENOCARCINOMA 15 0.0067
143 OXYGEN CONSUMPTION DECREASED 4 0.0066
144 EOSINOPHIL COUNT INCREASED 54 0.0065
145 VITAMIN D INCREASED 4 0.0065
146 DYSPNOEA EXERTIONAL 239 0.0063
147 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 303 0.0063
148 INCREASED VISCOSITY OF BRONCHIAL SECRETION 4 0.0063
149 HALO VISION 7 0.0062
150 PULMONARY PAIN 18 0.0062
151 AMNESTIC DISORDER 3 0.0062
152 DRUG DOSE OMISSION 1017 0.0061
153 BODY HEIGHT INCREASED 3 0.0061
154 MITE ALLERGY 4 0.0061
155 PRODUCT TASTE ABNORMAL 82 0.0060
156 CUSHINGOID 19 0.0059
157 RESPIRATORY TRACT IRRITATION 6 0.0057
158 UPPER-AIRWAY COUGH SYNDROME 47 0.0057
159 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 5 0.0057
160 FRUSTRATION TOLERANCE DECREASED 46 0.0057
161 BODY TEMPERATURE INCREASED 115 0.0056
162 VOCAL CORD DISORDER 11 0.0056
163 SPUTUM INCREASED 12 0.0055
164 NEUROPSYCHIATRIC SYMPTOMS 5 0.0055
165 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 186 0.0055
166 CREATININE RENAL CLEARANCE INCREASED 4 0.0053
167 DEVICE ISSUE 475 0.0053
168 BRONCHITIS BACTERIAL 4 0.0053
169 CORONARY ARTERY DISEASE 156 0.0051
170 LOWER RESPIRATORY TRACT INFECTION 233 0.0051
171 HYPOKINESIA 72 0.0050
172 TONGUE ERYTHEMA 4 0.0049
173 BLOOD PRESSURE SYSTOLIC INCREASED 94 0.0048
174 COVID-19 IMMUNISATION 4 0.0048
175 PULMONARY MASS 71 0.0048
176 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 339 0.0048
177 SLEEP APNOEA SYNDROME 90 0.0047
178 INTENTIONAL DEVICE USE ISSUE 4 0.0047
179 LUNG NEOPLASM MALIGNANT 191 0.0046
180 HYPOAESTHESIA ORAL 70 0.0046
181 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 11 0.0046
182 ANION GAP INCREASED 6 0.0045
183 BLOOD TEST ABNORMAL 63 0.0045
184 GASTROOESOPHAGEAL REFLUX DISEASE 358 0.0044
185 BODY MASS INDEX INCREASED 6 0.0044
186 HEPATOTOXICITY 98 0.0044
187 PRODUCT QUALITY ISSUE 592 0.0044
188 ORAL CANDIDIASIS 57 0.0043
189 BLOOD URINE PRESENT 81 0.0043
190 PULMONARY CONGESTION 55 0.0042
191 PERICARDIAL HAEMORRHAGE 9 0.0041
192 OVERWEIGHT 22 0.0041
193 BLOOD COUNT ABNORMAL 62 0.0041
194 SPUTUM RETENTION 4 0.0040
195 MULTIPLE ALLERGIES 31 0.0040
196 DIZZINESS EXERTIONAL 3 0.0039
197 DEVICE DEFECTIVE 68 0.0039
198 RESPIRATORY SYMPTOM 11 0.0039
199 BLOOD KETONE BODY INCREASED 3 0.0038
200 EAR PAIN 74 0.0038
201 LIMB DEFORMITY 6 0.0038
202 RENAL CYST 30 0.0038
203 DEVICE DAMAGE 3 0.0038
204 VENTRICULAR HYPOKINESIA 12 0.0037
205 PSEUDOMONAS INFECTION 32 0.0037
206 LIMB INJURY 101 0.0037
207 INFUSION SITE BRUISING 8 0.0037
208 BLOOD BILIRUBIN INCREASED 99 0.0037
209 GLAUCOMA 70 0.0036
210 LUNG DISORDER 175 0.0036
211 CAROTID ARTERY THROMBOSIS 3 0.0035
212 TRANSIENT ISCHAEMIC ATTACK 118 0.0035
213 EAR DISORDER 16 0.0035
214 PERIPHERAL VASCULAR DISORDER 18 0.0035
215 RHINITIS 28 0.0035
216 BLOOD CHOLESTEROL ABNORMAL 16 0.0035
217 GASTROENTERITIS 49 0.0034
218 MACULAR DEGENERATION 40 0.0033
219 REFLUX GASTRITIS 4 0.0033
220 SMALL CELL LUNG CANCER 5 0.0033
221 DYSPNOEA 1875 0.0033
222 BRONCHITIS 245 0.0033
223 PROSTATITIS 10 0.0033
224 PSYCHOTIC DISORDER 97 0.0033
225 SENSITIVITY TO WEATHER CHANGE 17 0.0032
226 PRODUCT DOSE OMISSION 210 0.0032
227 BRONCHIAL DISORDER 5 0.0032
228 CHOLELITHIASIS 103 0.0031
229 OSTEOPOROTIC FRACTURE 6 0.0031
230 INFUSION SITE NODULE 3 0.0031
231 PYELONEPHRITIS 27 0.0031
232 HYPOACUSIS 133 0.0031
233 DUST ALLERGY 3 0.0031
234 OXYGEN THERAPY 5 0.0030
235 TYMPANIC MEMBRANE PERFORATION 5 0.0030
236 URINE FLOW DECREASED 7 0.0029
237 RESTLESS LEGS SYNDROME 53 0.0029
238 ABSCESS 46 0.0029
239 MIDDLE INSOMNIA 53 0.0028
240 WRIST FRACTURE 34 0.0028
241 BONE DEMINERALISATION 3 0.0028
242 FANCONI SYNDROME 4 0.0028
243 SUFFOCATION FEELING 7 0.0028
244 DYSPHONIA 162 0.0028
245 RESPIRATION ABNORMAL 19 0.0028
246 DYSURIA 101 0.0027
247 INCREASED BRONCHIAL SECRETION 7 0.0027
248 SECRETION DISCHARGE 34 0.0027
249 TYPE 2 DIABETES MELLITUS 90 0.0027
250 CHOKING 52 0.0027
251 FEELING COLD 72 0.0026
252 DRUG DELIVERY SYSTEM ISSUE 5 0.0025
253 PROCEDURAL PAIN 70 0.0025
254 RESPIRATORY TRACT CONGESTION 40 0.0025
255 CHRONIC RESPIRATORY FAILURE 3 0.0025
256 CELLULITIS 125 0.0025
257 OXYGEN SATURATION ABNORMAL 7 0.0025
258 NEUROLOGICAL SYMPTOM 14 0.0024
259 SKIN LESION 65 0.0024
260 CATARACT 141 0.0024
261 VISUAL ACUITY REDUCED 78 0.0023
262 COUGH 658 0.0023
263 DEVICE USE ISSUE 41 0.0023
264 RIB FRACTURE 48 0.0023
265 PANIC ATTACK 85 0.0023
266 MOVEMENT DISORDER 74 0.0023
267 APHONIA 32 0.0023
268 FANCONI SYNDROME ACQUIRED 4 0.0023
269 DISABILITY 45 0.0023
270 NOSOCOMIAL INFECTION 5 0.0023
271 ARTERIOSCLEROSIS CORONARY ARTERY 15 0.0023
272 CANDIDA INFECTION 38 0.0022
273 HAEMATURIA 77 0.0022
274 PNEUMONIA 718 0.0022
275 CARBON DIOXIDE INCREASED 3 0.0022
276 OESOPHAGEAL SPASM 4 0.0022
277 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 101 0.0022
278 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
279 CHEST DISCOMFORT 217 0.0021
280 HEART RATE INCREASED 206 0.0021
281 DYSPNOEA AT REST 6 0.0021
282 PANIC DISORDER 8 0.0021
283 POLLAKIURIA 86 0.0021
284 NASAL SEPTUM DEVIATION 4 0.0020
285 CONJUNCTIVITIS ALLERGIC 3 0.0020
286 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
287 GASTRITIS HAEMORRHAGIC 3 0.0020
288 OROPHARYNGEAL DISCOMFORT 18 0.0020
289 POLYP 13 0.0020
290 SINUSITIS 203 0.0020
291 LUMBAR VERTEBRAL FRACTURE 9 0.0020
292 EAR DISCOMFORT 20 0.0019
293 INCREASED UPPER AIRWAY SECRETION 10 0.0019
294 EOSINOPHILIA 34 0.0019
295 CORONARY ARTERY BYPASS 11 0.0019
296 HYPOTHYROIDISM 61 0.0019
297 NASAL CONGESTION 112 0.0019
298 DYSARTHRIA 71 0.0019
299 PNEUMONIA VIRAL 6 0.0019
300 DRY THROAT 19 0.0019
301 RESPIRATORY DISORDER 55 0.0018
302 ABDOMINAL TENDERNESS 9 0.0018
303 BLOOD PRESSURE ABNORMAL 36 0.0018
304 CONCUSSION 14 0.0018
305 NEPHROLITHIASIS 81 0.0018
306 FEMALE GENITAL TRACT FISTULA 3 0.0018
307 READING DISORDER 4 0.0017
308 OSTEOPOROSIS 72 0.0017
309 ESCHERICHIA INFECTION 14 0.0017
310 BRONCHOSPASM 24 0.0017
311 CEREBROVASCULAR DISORDER 5 0.0017
312 RESPIRATORY TRACT INFECTION 43 0.0016
313 TONGUE DISCOMFORT 7 0.0016
314 SKIN FRAGILITY 4 0.0016
315 ASPIRATION 18 0.0016
316 BREATH ODOUR 4 0.0016
317 INTERVERTEBRAL DISC DISORDER 7 0.0016
318 OXYGEN SATURATION DECREASED 92 0.0016
319 OEDEMA PERIPHERAL 198 0.0016
320 HYPERVOLAEMIA 8 0.0016
321 HEPATIC ENZYME INCREASED 110 0.0016
322 HYPERPARATHYROIDISM SECONDARY 4 0.0016
323 URINARY RETENTION 53 0.0016
324 EYE DISORDER 52 0.0016
325 RESPIRATORY RATE INCREASED 14 0.0016
326 OBESITY 25 0.0016
327 LUNG INFECTION 24 0.0015
328 OROPHARYNGEAL PAIN 143 0.0015
329 CARDIAC FAILURE 124 0.0015
330 INFLUENZA 170 0.0015
331 RADICULOPATHY 4 0.0015
332 SYMPTOM RECURRENCE 9 0.0015
333 ANIMAL BITE 4 0.0015
334 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
335 BREAST MASS 10 0.0015
336 DECREASED ACTIVITY 16 0.0015
337 SPINAL COLUMN STENOSIS 7 0.0015
338 MEMORY IMPAIRMENT 201 0.0015
339 BLISTER 82 0.0015
340 ECZEMA 76 0.0015
341 CHEST INJURY 3 0.0014
342 HERNIA 28 0.0014
343 INSURANCE ISSUE 22 0.0014
344 OEDEMA 78 0.0014
345 BODY TEMPERATURE DECREASED 14 0.0014
346 RENAL TUBULAR DISORDER 4 0.0014
347 ORGANISING PNEUMONIA 7 0.0014
348 VISUAL IMPAIRMENT 174 0.0014
349 HEAD INJURY 44 0.0014
350 PANIC REACTION 10 0.0014
351 HYPERTENSION 291 0.0014
352 ENDOMETRIAL CANCER 3 0.0014
353 ACCIDENT AT WORK 3 0.0014
354 PSYCHIATRIC SYMPTOM 10 0.0014
355 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
356 WHEELCHAIR USER 6 0.0013
357 PLEURISY 8 0.0013
358 ATYPICAL PNEUMONIA 4 0.0013
359 INCORRECT DOSE ADMINISTERED BY DEVICE 35 0.0013
360 COLITIS ISCHAEMIC 9 0.0013
361 CHILLS 154 0.0013
362 HIATUS HERNIA 17 0.0013
363 HYPERTHYROIDISM 19 0.0013
364 MASTICATION DISORDER 4 0.0013
365 CLAVICLE FRACTURE 5 0.0013
366 RHINORRHOEA 84 0.0013
367 OESOPHAGEAL DISORDER 5 0.0013
368 IDIOPATHIC PULMONARY FIBROSIS 5 0.0013
369 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
370 NEUTROPENIC SEPSIS 9 0.0013
371 HAEMOPTYSIS 35 0.0013
372 IMPAIRED QUALITY OF LIFE 18 0.0013
373 DYSGEUSIA 93 0.0013
374 ATELECTASIS 12 0.0012
375 MUSCULOSKELETAL DISCOMFORT 21 0.0012
376 HYPOGAMMAGLOBULINAEMIA 8 0.0012
377 EXERCISE TOLERANCE DECREASED 7 0.0012
378 IMMUNE SYSTEM DISORDER 16 0.0012
379 DEVICE INFUSION ISSUE 3 0.0012
380 SKIN INJURY 4 0.0012
381 MUSCULAR WEAKNESS 137 0.0012
382 INFLUENZA LIKE ILLNESS 99 0.0012
383 SINUS TACHYCARDIA 17 0.0012
384 ACUTE RESPIRATORY FAILURE 23 0.0012
385 POST-TRAUMATIC STRESS DISORDER 8 0.0012
386 QUALITY OF LIFE DECREASED 16 0.0012
387 HEAD DISCOMFORT 21 0.0012
388 AORTIC ANEURYSM 9 0.0012
389 BLOOD PRESSURE DIASTOLIC ABNORMAL 3 0.0012
390 PRODUCT LABEL ISSUE 8 0.0012
391 HAEMOGLOBIN DECREASED 121 0.0012
392 DRUG DELIVERY SYSTEM MALFUNCTION 6 0.0012
393 REGURGITATION 4 0.0012
394 BLOOD PRESSURE INCREASED 178 0.0012
395 ATRIAL FIBRILLATION 113 0.0012
396 CATHETER SITE PAIN 3 0.0012
397 BASAL CELL CARCINOMA 18 0.0012
398 HYPOPNOEA 4 0.0012
399 PULMONARY HYPERTENSION 24 0.0012
400 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
401 CAROTID ARTERY STENOSIS 4 0.0011
402 WOUND 32 0.0011
403 MELAENA 25 0.0011
404 CARDIAC FAILURE CONGESTIVE 91 0.0011
405 LUNG INFILTRATION 10 0.0011
406 BURNING SENSATION 79 0.0011
407 BALANCE DISORDER 97 0.0011
408 CONDITION AGGRAVATED 340 0.0011
409 SPONDYLITIS 4 0.0011
410 HICCUPS 9 0.0011
411 FOOD INTOLERANCE 4 0.0011
412 GAIT DISTURBANCE 209 0.0011
413 ACCIDENT 13 0.0011
414 PRODUCT DOSE OMISSION ISSUE 320 0.0011
415 DRUG SCREEN FALSE POSITIVE 3 0.0011
416 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
417 UPPER RESPIRATORY TRACT INFECTION 50 0.0011
418 ORAL DISCOMFORT 15 0.0011
419 SYSTEMIC LUPUS ERYTHEMATOSUS 38 0.0011
420 SNEEZING 24 0.0011
421 PRODUCT USE ISSUE 201 0.0011
422 BEDRIDDEN 14 0.0011
423 PAROSMIA 8 0.0011
424 GOUT 19 0.0011
425 UNDERDOSE 77 0.0011
426 VITAMIN D DECREASED 9 0.0011
427 PRODUCT PACKAGING ISSUE 10 0.0011
428 WEIGHT FLUCTUATION 11 0.0011
429 HEART VALVE INCOMPETENCE 3 0.0010
430 BLOOD URIC ACID INCREASED 6 0.0010
431 SINUS CONGESTION 14 0.0010
432 HYPERVENTILATION 6 0.0010
433 BILIARY COLIC 3 0.0010
434 PERIPHERAL SWELLING 157 0.0010
435 NERVOUSNESS 53 0.0010
436 ATAXIA 12 0.0010
437 SYNCOPE 101 0.0010
438 HYPERLIPIDAEMIA 12 0.0010
439 EXTRASYSTOLES 7 0.0010
440 FOREIGN BODY 4 0.0010
441 BLOOD PRESSURE INADEQUATELY CONTROLLED 6 0.0010
442 WEIGHT DECREASED 278 0.0010
443 FOOT DEFORMITY 11 0.0010
444 MIGRAINE 94 0.0010
445 ENDOCARDITIS 5 0.0010
446 DIABETES MELLITUS 74 0.0010
447 TEMPERATURE INTOLERANCE 10 0.0010
448 PRODUCT USE IN UNAPPROVED INDICATION 238 0.0010
449 FLANK PAIN 9 0.0010
450 PNEUMOTHORAX 15 0.0009
451 DRY MOUTH 76 0.0009
452 COMPRESSION FRACTURE 5 0.0009
453 PRODUCT RESIDUE PRESENT 5 0.0009
454 WEIGHT INCREASED 207 0.0009
455 VITAMIN D DEFICIENCY 9 0.0009
456 SEASONAL ALLERGY 13 0.0009
457 PULMONARY OEDEMA 41 0.0009
458 HAEMORRHAGIC ANAEMIA 4 0.0009
459 CHOKING SENSATION 5 0.0009
460 RESPIRATORY DISTRESS 25 0.0009
461 MUSCULOSKELETAL CHEST PAIN 14 0.0009
462 ANXIETY DISORDER 3 0.0009
463 CARDIAC DISORDER 84 0.0009
464 HEART RATE ABNORMAL 5 0.0009
465 DEMENTIA 25 0.0009
466 MALAISE 392 0.0009
467 URINARY TRACT DISORDER 4 0.0009
468 ABDOMINAL DISTENSION 92 0.0009
469 ABNORMAL LOSS OF WEIGHT 6 0.0009
470 NASOPHARYNGITIS 162 0.0009
471 CORONARY ARTERY OCCLUSION 12 0.0009
472 THROAT IRRITATION 39 0.0009
473 MUSCLE DISORDER 7 0.0009
474 DYSPEPSIA 85 0.0009
475 NEPHROGENIC ANAEMIA 4 0.0009
476 BACK DISORDER 14 0.0009
477 HERPES ZOSTER 49 0.0009
478 COVID-19 PNEUMONIA 10 0.0008
479 DIVERTICULUM 6 0.0008
480 FOOT FRACTURE 16 0.0008
481 THYROID DISORDER 13 0.0008
482 NODULE 11 0.0008
483 FALL 280 0.0008
484 ANKLE FRACTURE 13 0.0008
485 EXTRA DOSE ADMINISTERED 34 0.0008
486 EYE INFLAMMATION 8 0.0008
487 FACIAL BONES FRACTURE 3 0.0008
488 BACK INJURY 9 0.0008
489 END STAGE RENAL DISEASE 15 0.0008
490 OFF LABEL USE 720 0.0008
491 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
492 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
493 HIP FRACTURE 26 0.0008
494 BLADDER DISORDER 8 0.0008
495 MYOCARDIAL INFARCTION 140 0.0008
496 NASAL DRYNESS 5 0.0008
497 HYPOXIA 28 0.0008
498 BLOOD CHOLESTEROL INCREASED 37 0.0008
499 AUTOIMMUNE THYROIDITIS 3 0.0008
500 CHOLECYSTECTOMY 9 0.0008
501 VIRAL INFECTION 26 0.0008
502 DERMATITIS ATOPIC 41 0.0008
503 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
504 SLEEP DISORDER 54 0.0008
505 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
506 INCORRECT DOSE ADMINISTERED 173 0.0008
507 INFLAMMATION 39 0.0008
508 ATRIAL FLUTTER 6 0.0008
509 SPINAL FRACTURE 15 0.0007
510 DRUG DEPENDENCE 119 0.0007
511 CHEST PAIN 136 0.0007
512 WOUND INFECTION 8 0.0007
513 STAPHYLOCOCCAL INFECTION 24 0.0007
514 ARTHRITIS 57 0.0007
515 AGEUSIA 18 0.0007
516 GASTROENTERITIS VIRAL 13 0.0007
517 NERVE INJURY 8 0.0007
518 INTENTIONAL PRODUCT USE ISSUE 63 0.0007
519 DYSPHAGIA 68 0.0007
520 INFUSION SITE ERYTHEMA 6 0.0007
521 BLINDNESS 29 0.0007
522 CARDIAC VALVE DISEASE 4 0.0007
523 PNEUMONITIS 19 0.0007
524 BONE CANCER 3 0.0007
525 IMMOBILE 3 0.0007
526 GROIN PAIN 6 0.0007
527 ACUTE MYOCARDIAL INFARCTION 20 0.0007
528 CATHETERISATION CARDIAC 3 0.0007
529 ILL-DEFINED DISORDER 41 0.0007
530 ARTHROPOD BITE 5 0.0007
531 SINUS HEADACHE 4 0.0007
532 TENDERNESS 7 0.0007
533 GASTROINTESTINAL INFECTION 6 0.0007
534 THROAT TIGHTNESS 18 0.0007
535 URINARY TRACT INFECTION 113 0.0007
536 LOCALISED INFECTION 16 0.0007
537 RENAL PAIN 7 0.0007
538 ILLNESS 68 0.0007
539 MUSCLE SPASMS 121 0.0007
540 BACK PAIN 153 0.0007
541 ABDOMINAL HERNIA 3 0.0007
542 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
543 HUNGER 9 0.0006
544 SCOLIOSIS 4 0.0006
545 PHARYNGITIS 8 0.0006
546 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
547 HAEMORRHAGIC STROKE 5 0.0006
548 TREMOR 106 0.0006
549 OSTEOARTHRITIS 27 0.0006
550 PYREXIA 220 0.0006
551 INFUSION SITE SWELLING 4 0.0006
552 SPINAL DISORDER 6 0.0006
553 NASAL DISCOMFORT 5 0.0006
554 PARAESTHESIA ORAL 9 0.0006
555 FEELING ABNORMAL 149 0.0006
556 GUILLAIN-BARRE SYNDROME 3 0.0006
557 STENT PLACEMENT 5 0.0006
558 TACHYCARDIA 55 0.0006
559 CARDIAC FLUTTER 4 0.0006
560 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
561 ANGINA UNSTABLE 4 0.0006
562 INCORRECT DOSAGE ADMINISTERED 3 0.0006
563 PHARYNGEAL SWELLING 6 0.0006
564 ASPHYXIA 5 0.0006
565 MOBILITY DECREASED 44 0.0006
566 MYALGIA 104 0.0006
567 DECREASED APPETITE 142 0.0006
568 SPINAL COMPRESSION FRACTURE 5 0.0006
569 INABILITY TO AFFORD MEDICATION 6 0.0006
570 UPPER LIMB FRACTURE 12 0.0006
571 EAR INFECTION 16 0.0006
572 BRAIN INJURY 6 0.0006
573 SPEECH DISORDER 31 0.0006
574 THINKING ABNORMAL 11 0.0006
575 TOOTH ABSCESS 6 0.0006
576 DEPRESSION 133 0.0006
577 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
578 ECCHYMOSIS 4 0.0006
579 PAIN IN EXTREMITY 171 0.0006
580 FIBROMYALGIA 14 0.0006
581 PLEURAL EFFUSION 35 0.0006
582 BLOOD LACTIC ACID INCREASED 3 0.0006
583 CARDIOMEGALY 7 0.0006
584 AMNESIA 37 0.0006
585 IRRITABILITY 34 0.0006
586 THERAPY CESSATION 29 0.0006
587 RETCHING 12 0.0006
588 GALLBLADDER DISORDER 10 0.0006
589 ANAL ABSCESS 3 0.0006
590 VISION BLURRED 76 0.0006
591 VISUAL FIELD DEFECT 4 0.0006
592 PNEUMONIA BACTERIAL 5 0.0005
593 SWOLLEN TONGUE 17 0.0005
594 BRAIN NEOPLASM 5 0.0005
595 TASTE DISORDER 11 0.0005
596 CEREBRAL DISORDER 4 0.0005
597 HYPERTENSIVE CRISIS 6 0.0005
598 ORAL PAIN 12 0.0005
599 PERICARDITIS 9 0.0005
600 NEPHROPATHY 5 0.0005
601 ANGIOPATHY 3 0.0005
602 SKIN INFECTION 6 0.0005
603 OCULAR DISCOMFORT 6 0.0005
604 LACERATION 5 0.0005
605 CHOLECYSTITIS ACUTE 3 0.0005
606 OSTEOPENIA 8 0.0005
607 TROPONIN INCREASED 4 0.0005
608 OSTEONECROSIS OF JAW 13 0.0005
609 FEELING JITTERY 10 0.0005
610 DRUG DISPENSING ERROR 8 0.0005
611 MOUTH ULCERATION 11 0.0005
612 JOINT RANGE OF MOTION DECREASED 7 0.0005
613 DEVICE USE ERROR 18 0.0005
614 PRESCRIBED OVERDOSE 10 0.0005
615 TENDONITIS 8 0.0005
616 PELVIC FRACTURE 4 0.0005
617 DEVICE DELIVERY SYSTEM ISSUE 14 0.0005
618 KIDNEY INFECTION 10 0.0005
619 ANXIETY 145 0.0005
620 HYPERSENSITIVITY 94 0.0005
621 HOSPICE CARE 5 0.0005
622 MEDICATION ERROR 28 0.0005
623 HEARING IMPAIRED 3 0.0005
624 BLOOD PRESSURE FLUCTUATION 12 0.0005
625 SALIVARY HYPERSECRETION 5 0.0005
626 BONE DISORDER 9 0.0005
627 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 100 0.0005
628 MOTOR DYSFUNCTION 5 0.0005
629 HAEMATOCHEZIA 27 0.0005
630 HEART RATE IRREGULAR 11 0.0005
631 PARAESTHESIA 76 0.0005
632 NEOPLASM MALIGNANT 32 0.0005
633 CONTUSION 46 0.0005
634 SCRATCH 5 0.0005
635 ABDOMINAL PAIN 110 0.0005
636 FLUID RETENTION 24 0.0005
637 ROTATOR CUFF SYNDROME 6 0.0005
638 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
639 PRODUCT CONTAINER ISSUE 4 0.0005
640 BLOOD PRESSURE DECREASED 31 0.0005
641 HAEMOGLOBIN ABNORMAL 3 0.0005
642 INCOHERENT 3 0.0005
643 UNEVALUABLE EVENT 35 0.0005
644 PULMONARY THROMBOSIS 5 0.0005
645 URINE OUTPUT DECREASED 4 0.0005
646 ADVERSE DRUG REACTION 41 0.0005
647 DYSGRAPHIA 3 0.0005
648 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
649 SARS-COV-2 TEST POSITIVE 6 0.0005
650 CARDIAC FAILURE ACUTE 3 0.0004
651 HYPERHIDROSIS 58 0.0004
652 GENERAL PHYSICAL HEALTH DETERIORATION 52 0.0004
653 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
654 PRODUCT ADMINISTRATION ERROR 9 0.0004
655 DYSSTASIA 13 0.0004
656 DRUG INTOLERANCE 43 0.0004
657 PRODUCT USE COMPLAINT 7 0.0004
658 EYE INFECTION 5 0.0004
659 CEREBROVASCULAR ACCIDENT 75 0.0004
660 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
661 PULMONARY EMBOLISM 42 0.0004
662 LIP DRY 4 0.0004
663 SCAB 5 0.0004
664 INTERNAL HAEMORRHAGE 5 0.0004
665 TOOTH LOSS 9 0.0004
666 OVARIAN CANCER 4 0.0004
667 DIVERTICULITIS 12 0.0004
668 ASTHENIA 162 0.0004
669 ELECTROLYTE IMBALANCE 5 0.0004
670 LACRIMATION INCREASED 13 0.0004
671 HYPOPHAGIA 11 0.0004
672 POST PROCEDURAL HAEMORRHAGE 5 0.0004
673 BACTERIAL INFECTION 8 0.0004
674 DEVICE OCCLUSION 6 0.0004
675 HEPATIC CIRRHOSIS 8 0.0004
676 HAEMATOMA 11 0.0004
677 DIPLOPIA 11 0.0004
678 HAND FRACTURE 3 0.0004
679 GASTRIC ULCER 8 0.0004
680 FUNGAL INFECTION 14 0.0004
681 VOMITING 197 0.0004
682 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
683 POLYNEUROPATHY 5 0.0004
684 LOWER LIMB FRACTURE 8 0.0004
685 HEPATITIS C 5 0.0004
686 PALPITATIONS 48 0.0004
687 CYSTITIS 13 0.0004
688 TENDON RUPTURE 5 0.0004
689 ANAEMIA 77 0.0004
690 DRY EYE 20 0.0004
691 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
692 DIZZINESS 198 0.0004
693 CONFUSIONAL STATE 64 0.0004
694 BRADYCARDIA 21 0.0004
695 VAGINAL DISCHARGE 4 0.0004
696 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
697 MUSCLE ATROPHY 5 0.0004
698 NECK PAIN 22 0.0004
699 DISCOMFORT 24 0.0004
700 FATIGUE 306 0.0004
701 HEADACHE 246 0.0004
702 BOWEL MOVEMENT IRREGULARITY 3 0.0004
703 RENAL FAILURE 52 0.0004
704 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
705 LIP SWELLING 13 0.0004
706 SEIZURE 45 0.0004
707 PERICARDIAL EFFUSION 9 0.0004
708 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
709 GAIT INABILITY 13 0.0004
710 ATRIOVENTRICULAR BLOCK 3 0.0004
711 LIMB DISCOMFORT 12 0.0004
712 APHTHOUS ULCER 3 0.0004
713 ARTHRALGIA 160 0.0004
714 INCORRECT PRODUCT STORAGE 5 0.0004
715 GINGIVAL PAIN 3 0.0004
716 SCIATICA 6 0.0004
717 BREAST CANCER FEMALE 10 0.0004
718 FEAR 10 0.0004
719 SKIN CANCER 8 0.0004
720 MENTAL IMPAIRMENT 9 0.0004
721 COLITIS 14 0.0004
722 ADVERSE EVENT 34 0.0004
723 CHRONIC KIDNEY DISEASE 28 0.0004
724 DECUBITUS ULCER 3 0.0004
725 INSOMNIA 98 0.0004
726 BLOOD GLUCOSE FLUCTUATION 4 0.0004
727 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
728 VERTIGO 22 0.0004
729 COAGULOPATHY 6 0.0004
730 TOOTH DISORDER 8 0.0004
731 MITRAL VALVE INCOMPETENCE 4 0.0004
732 BONE DENSITY DECREASED 11 0.0004
733 SCAR 6 0.0004
734 BLOOD MAGNESIUM DECREASED 3 0.0003
735 FEEDING DISORDER 7 0.0003
736 DRUG DOSE OMISSION BY DEVICE 27 0.0003
737 RESPIRATORY FAILURE 25 0.0003
738 DEPRESSED MOOD 18 0.0003
739 FLATULENCE 19 0.0003
740 DRUG EFFECT DECREASED 18 0.0003
741 INFECTION 48 0.0003
742 OSTEOMYELITIS 6 0.0003
743 ADRENAL INSUFFICIENCY 4 0.0003
744 EATING DISORDER 7 0.0003
745 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
746 SPINAL OPERATION 4 0.0003
747 LYMPHOMA 5 0.0003
748 PRURITUS 124 0.0003
749 RENAL DISORDER 15 0.0003
750 TOOTH EXTRACTION 4 0.0003
751 RENAL IMPAIRMENT 27 0.0003
752 COGNITIVE DISORDER 15 0.0003
753 GASTRIC DISORDER 11 0.0003
754 PNEUMONIA ASPIRATION 8 0.0003
755 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
756 HYPONATRAEMIA 18 0.0003
757 PAIN 196 0.0003
758 HYPOTENSION 64 0.0003
759 ARTERIOSCLEROSIS 3 0.0003
760 BLOOD SODIUM DECREASED 6 0.0003
761 ABDOMINAL DISCOMFORT 53 0.0003
762 ULCER 5 0.0003
763 HYPERSOMNIA 9 0.0003
764 DRUG INEFFECTIVE 413 0.0003
765 INTRAOCULAR PRESSURE INCREASED 4 0.0003
766 POST PROCEDURAL COMPLICATION 6 0.0003
767 DRUG PRESCRIBING ERROR 6 0.0003
768 RASH 136 0.0003
769 ERUCTATION 6 0.0003
770 PRODUCT AVAILABILITY ISSUE 7 0.0003
771 HEPATOMEGALY 3 0.0003
772 DIARRHOEA 197 0.0003
773 RECTAL HAEMORRHAGE 13 0.0003
774 EYE PAIN 17 0.0003
775 SKIN DISORDER 10 0.0003
776 BLOOD POTASSIUM DECREASED 9 0.0003
777 MENTAL DISORDER 13 0.0003
778 THERAPEUTIC RESPONSE DECREASED 18 0.0003
779 LOSS OF CONSCIOUSNESS 38 0.0003
780 LETHARGY 17 0.0003
781 NEUTROPHIL COUNT DECREASED 12 0.0003
782 HYPOAESTHESIA 44 0.0003
783 HOSPITALISATION 45 0.0003
784 FEMUR FRACTURE 9 0.0003
785 EYE DISCHARGE 3 0.0003
786 PRESYNCOPE 7 0.0003
787 NEURALGIA 7 0.0003
788 INJECTION SITE PAIN 88 0.0003
789 MASS 4 0.0003
790 COLD SWEAT 5 0.0003
791 BLINDNESS UNILATERAL 4 0.0003
792 MOOD SWINGS 9 0.0003
793 INTENTIONAL DOSE OMISSION 8 0.0003
794 PARALYSIS 4 0.0003
795 MYELODYSPLASTIC SYNDROME 4 0.0003
796 BIPOLAR DISORDER 3 0.0003
797 FLUID OVERLOAD 4 0.0003
798 ACUTE KIDNEY INJURY 42 0.0003
799 ANAPHYLACTIC REACTION 15 0.0003
800 EXPIRED PRODUCT ADMINISTERED 9 0.0003
801 NAUSEA 214 0.0003
802 URINARY INCONTINENCE 8 0.0003
803 ARTHROPATHY 15 0.0003
804 RENAL INJURY 8 0.0003
805 INTERSTITIAL LUNG DISEASE 13 0.0003
806 HEPATIC STEATOSIS 5 0.0003
807 EYE PRURITUS 9 0.0003
808 HAEMORRHAGE 28 0.0003
809 FISTULA 3 0.0003
810 FRACTURE 5 0.0003
811 IMPAIRED DRIVING ABILITY 3 0.0003
812 PHARYNGEAL OEDEMA 4 0.0003
813 DELIRIUM 9 0.0003
814 LYMPHADENOPATHY 9 0.0003
815 OCULAR HYPERAEMIA 12 0.0003
816 ANGIOEDEMA 11 0.0002
817 PRODUCT PHYSICAL ISSUE 5 0.0002
818 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
819 GASTROINTESTINAL DISORDER 22 0.0002
820 ABDOMINAL PAIN UPPER 50 0.0002
821 VENTRICULAR TACHYCARDIA 4 0.0002
822 DEVICE DIFFICULT TO USE 16 0.0002
823 TINNITUS 11 0.0002
824 SKIN DISCOLOURATION 11 0.0002
825 URTICARIA 40 0.0002
826 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 43 0.0002
827 HYPOKALAEMIA 11 0.0002
828 THERAPY INTERRUPTED 17 0.0002
829 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
830 THROMBOSIS 19 0.0002
831 IRRITABLE BOWEL SYNDROME 5 0.0002
832 INFUSION SITE PAIN 3 0.0002
833 PRURITUS GENERALISED 5 0.0002
834 FAECES DISCOLOURED 5 0.0002
835 DEAFNESS 6 0.0002
836 LOCAL SWELLING 4 0.0002
837 CONSTIPATION 50 0.0002
838 ANHEDONIA 6 0.0002
839 GASTRITIS 6 0.0002
840 HEART RATE DECREASED 8 0.0002
841 METASTASES TO LIVER 4 0.0002
842 EPISTAXIS 17 0.0002
843 COVID-19 39 0.0002
844 CHROMATURIA 5 0.0002
845 DRUG EFFECT INCOMPLETE 8 0.0002
846 RHEUMATOID ARTHRITIS 25 0.0002
847 MOOD ALTERED 6 0.0002
848 NIGHT SWEATS 7 0.0002
849 CONJUNCTIVITIS 4 0.0002
850 JOINT SWELLING 26 0.0002
851 ROAD TRAFFIC ACCIDENT 9 0.0002
852 FEELING HOT 13 0.0002
853 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
854 PAIN IN JAW 6 0.0002
855 ARRHYTHMIA 10 0.0002
856 MUSCULOSKELETAL PAIN 11 0.0002
857 PRODUCT PRESCRIBING ERROR 5 0.0002
858 ANGINA PECTORIS 6 0.0002
859 SOMNOLENCE 42 0.0002
860 PULMONARY FIBROSIS 4 0.0002
861 DEVICE LEAKAGE 9 0.0002
862 ANGER 7 0.0002
863 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
864 DYSTONIA 4 0.0002
865 HAEMORRHOIDS 4 0.0002
866 CEREBRAL INFARCTION 5 0.0002
867 ABASIA 5 0.0002
868 DRUG INTERACTION 32 0.0002
869 COLON CANCER 3 0.0002
870 IMMUNODEFICIENCY 3 0.0002
871 SWELLING FACE 13 0.0002
872 BONE LOSS 3 0.0002
873 CEREBRAL HAEMORRHAGE 7 0.0002
874 DRUG ADMINISTRATION ERROR 6 0.0002
875 CARDIAC ARREST 16 0.0002
876 EJECTION FRACTION DECREASED 3 0.0002
877 PSORIASIS 25 0.0002
878 DEATH 164 0.0002
879 DEHYDRATION 25 0.0002
880 POOR QUALITY SLEEP 4 0.0002
881 LACTIC ACIDOSIS 6 0.0002
882 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
883 PRODUCT PRESCRIBING ISSUE 4 0.0002
884 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
885 STOMATITIS 11 0.0002
886 PLATELET COUNT DECREASED 19 0.0002
887 DISORIENTATION 7 0.0002
888 EMOTIONAL DISTRESS 21 0.0002
889 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
890 MUSCULOSKELETAL STIFFNESS 15 0.0002
891 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
892 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
893 NEUROPATHY PERIPHERAL 16 0.0002
894 BLOOD GLUCOSE DECREASED 8 0.0002
895 TREATMENT NONCOMPLIANCE 9 0.0002
896 AGITATION 12 0.0002
897 BLOOD GLUCOSE ABNORMAL 3 0.0002
898 SWELLING 15 0.0002
899 INTESTINAL OBSTRUCTION 6 0.0002
900 CARDIOVASCULAR DISORDER 4 0.0002
901 INCREASED APPETITE 3 0.0002
902 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
903 PRODUCT SUBSTITUTION ISSUE 9 0.0002
904 DRUG RESISTANCE 4 0.0002
905 ANAPHYLACTIC SHOCK 4 0.0002
906 SKIN ULCER 4 0.0002
907 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
908 RASH GENERALISED 4 0.0002
909 SUICIDAL IDEATION 14 0.0002
910 SEPSIS 17 0.0002
911 FEBRILE NEUTROPENIA 10 0.0002
912 FULL BLOOD COUNT DECREASED 3 0.0001
913 DISTURBANCE IN ATTENTION 8 0.0001
914 FREQUENT BOWEL MOVEMENTS 4 0.0001
915 PALLOR 4 0.0001
916 DERMATITIS 3 0.0001
917 PANCREATIC CARCINOMA 4 0.0001
918 CRYING 5 0.0001
919 HYPERGLYCAEMIA 5 0.0001
920 PROSTATE CANCER 11 0.0001
921 ACCIDENTAL OVERDOSE 5 0.0001
922 BONE PAIN 8 0.0001
923 COLITIS ULCERATIVE 6 0.0001
924 GLOSSODYNIA 3 0.0001
925 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
926 APHASIA 4 0.0001
927 PANCREATITIS 7 0.0001
928 NERVOUS SYSTEM DISORDER 4 0.0001
929 ABNORMAL BEHAVIOUR 5 0.0001
930 DEVICE BREAKAGE 5 0.0001
931 DYSKINESIA 5 0.0001
932 BLOOD GLUCOSE INCREASED 23 0.0001
933 ERYTHEMA 25 0.0001
934 AGGRESSION 6 0.0001
935 HOT FLUSH 9 0.0001
936 BLADDER CANCER 7 0.0001
937 ABDOMINAL PAIN LOWER 3 0.0001
938 FLUSHING 12 0.0001
939 BREAST CANCER 11 0.0001
940 SEPTIC SHOCK 5 0.0001
941 HYPERKALAEMIA 4 0.0001
942 PRODUCT ADHESION ISSUE 4 0.0001
943 OVERDOSE 24 0.0001
944 RASH PRURITIC 6 0.0001
945 C-REACTIVE PROTEIN INCREASED 4 0.0001
946 EYE SWELLING 4 0.0001
947 BLOOD CREATININE INCREASED 7 0.0001
948 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
949 INFUSION RELATED REACTION 7 0.0001
950 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
951 INJECTION SITE PRURITUS 7 0.0001
952 EYE IRRITATION 6 0.0001
953 PRODUCT STORAGE ERROR 9 0.0001
954 ASCITES 3 0.0001
955 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
956 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
957 SKIN BURNING SENSATION 7 0.0001
958 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
959 DEEP VEIN THROMBOSIS 6 0.0001
960 IMPAIRED HEALING 3 0.0001
961 INJECTION SITE SWELLING 7 0.0001
962 DEPENDENCE 5 0.0001
963 THERAPY NON-RESPONDER 4 0.0001
964 SKIN IRRITATION 4 0.0001
965 SURGERY 5 0.0001
966 HALLUCINATION 6 0.0001
967 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
968 DISEASE PROGRESSION 9 0.0001
969 DRY SKIN 10 0.0001
970 ALOPECIA 13 0.0001
971 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
972 COMA 3 0.0001
973 COMPLETED SUICIDE 5 0.0001
974 INJECTION SITE ERYTHEMA 7 0.0001
975 TREATMENT FAILURE 4 0.0000
976 EXPOSURE DURING PREGNANCY 3 0.0000
977 DRUG WITHDRAWAL SYNDROME 4 0.0000
978 INJURY 3 0.0000
979 ACNE 3 0.0000
980 NO ADVERSE EVENT 7 0.0000
981 INJECTION SITE HAEMORRHAGE 3 0.0000
982 THROMBOCYTOPENIA 4 0.0000
983 NEUTROPENIA 4 0.0000
984 TOXICITY TO VARIOUS AGENTS 4 0.0000